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We have induced photoallergy in mice to systemically 
administered drugs, specifically sulfanilamide and 
chlorpromazine. Mice were photosensitized to systemic 
sulfanilamide or chlorpromazine by i.p. administration 
of drug followed by UVB and UV A irradiation of shaved 
flank skin, on two consecutive days. Control mice re-
ceived i.p. drug with no irradiation. In some experi-
ments cyclophosphamide pretreatment, or intradermal 
Corynebacterium parvum (Propionibacterium acnes), 
was administered as an immunoadjuvant. All animals 
were photochallenged on day 5 with i.p. drug followed 
by UVA irradiation of one ear. Mice that had been 
previously immunized with drug and UV radiation de-
veloped ear swelling and erythema, evident 24 h after 
photochallenge, but not at 4 h . Control animals showed 
no reactions. In a typical experiment of photosensitiza-
tion to systemic sulfanilamide, the experimental group 
had a mean increase in ear thickness of 6.0 x 10-2 mm 
24 h after photochallenge, while unsensitized control 
animals showed a mean change of -0.8 x 10-2 mm. The 
histopathology of the positive challenge reaction was 
characteristic of a delayed type hypersensitivity. Adop-
tive transfer of photoallergy to systemic sulfanilamide 
to naive r ecipients was accomplished by i.v. injection of 
lymph node cells (5 x 107 ) harvested from actively pho-
tosensitized donors. Clinical reports have suggested that 
exposure to systemic medications followed by sunlight 
can induce an eruption having a photoallergic basis. We 
now report the first experimental proof of that hy poth-
esis. The murine model should facilitate exploration of 
photoallergic mechanisms and, in addition, it provides 
the basis for a prospective test of systemic drugs for 
their photoallergenicity. 
Photoa ll ergic dermatit is is an immunologica lly mediated, 
acquired altered reactivity that involves both chemica l (the 
photosensiti zer) and li ght (usua lly ul t rav iolet). Photoa llergic 
de rmatitis to systemic drugs denotes oral or pa renteral adm in -
istration of photosensitizer, whereas, t he more common entity, 
photoallergic contact dermatiti s, arises from the percutaneous 
application of t he photocontact all ergen. 
P hotoallergic contact dermatiti s is a well -studied entity. It 
has been experimentally induced in 3 species: human , guinea 
pig, and mouse, using substances such as: t he halogenated 
salicy l anilide~ [1 - 9], bithionol [6- 9], sulfanilamide [9- 12], 
mus k ambrette [9,13], 6-methylcoumari n [2,9,14), 7-methylcou-
marin [9], benzocaine [9], ch lorpromazine [2,9,15], and hexa-
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Abb reviations: 
C PZ: chl orpromazine 
Cy: cyclophospha mide 
DNFB: 1-lluoro-2,4 -dinit robenze ne 
PHABSA: pa ra-hydroxylamino benzene sulfona mide 
sulfa: sulfa nilamide 
T CSA: 3 , ~!' ,4 ',5 -tetrachlorosalicylanilide 
chlorophene [9, 16]. Photoallergic contact dermatitis has been 
shown to be a ce ll -mediated, delayed t ype hyp ersensit ivity 
reaction, t hat can be transfe rred to na ive recipients wit h lymph 
node cells from sensiti zed donors [2,17- 19]. 
Clinically, photoallergic reactions induced by systemic drugs 
a re less common and less well understood t han cutaneous 
reactions induced by topical photoa llerge ns [19]. Although the 
li te rature contains many case reports of pat ients who developed 
a photodistribut ion eruption a fter oral administration of drug 
and sunlight exposure, most of t hese case reports are desc riptive 
only, lack controls, and do not decisively demonstrate that 
system ica lly administered drugs can induce photoa llergy. The 
list of medications implicated in t hi s setting includes: sulfanil -
amide [20- 24 ], Nadisan [25], chlorpropamide [26], chlorpro-
mazine [27- 29], promethazine [30,31], hydrochlorothiazide 
[32], chlorothiazide [32,33 ], chlordiazepoxide [34], ca lcium cy-
clamate (35,36], and griseofulvin (36]. 
Indeed, t he concept of photoallergic dermatitis aris ing exclu-
s ively from systemica lly administe red chemical is doubted by 
some authors [37,38]. In the context of low-molecula r-weight 
contact a llerge ns, t he oral and pa renteral rou tes of administra-
t ion a re traditionally considered to induce immunologic toler -
ance rather t han allergic sensiti zation [39,40]. Whether t he 
systemic administration of photosensit ize r in a situation en-
tirely void of cutaneous application can induce photoallergy , 
has been a question that remained unanswered. 
We now report the experimental induction of photoallergic 
dermatit is in a mouse model using each of two systemica lly 
administe red drugs: sulfanil amide (sulfa) and chlorpromazine 
(CPZ) . For both photosensitization and photocha llenge, the 
drug was administered i.p. followed by UV irradiation of a skin 
s ite. Percutaneous application of photoallerge n to t he skin was 
ca refully excluded. Skin spec imens taken from sites of positive 
cha llenge reactions demonstrated t he hi stologic pattern typica l 
of the delayed type hypersensitivi ty reactions seen with pho-
toallergic contact dermatitis induced by topica l photosensiti z-
ers in mice. 
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MATERIALS AND METHODS 
Mice 
BALB/ c X A mice were purchased from the Jackso n Laboratory 
(Bar Ha rbor, Maine). All mice were housed in plastic cages, wit h 
Easilitter Chlorophyll 9061 (Westminster Scientific, Inc .. Westmi nster, 
Maryla nd) for bedding. The mice were fed fresh Ralston Purina Au -
toclavable Rodent Labora to ry Chow #5010 (St. Louis, Missouri ), a nd 
had unlimited access to ac idi fied water; antibiotics were not used. The 
mouse colony was kept in a tempera! ure-cont rolled, light -cycled room. 
The ages of the mice ranged from 9- 17 weeks, and their weight varied 
from 15- 30 g. In each individual experiment, mice were age - and weight · 
ma tched. 
Chemical.~ 
Sulfanila mide (4-aminosulfona mide) was purchased from Matheson 
Colema n and Bell (East Rutherford, New J ersey). Chlorp romazine 
hydroc hloride was a gift from S mith Kline & French Laborato ries 
(Philade lphia, Pennsylvania). Purchase was made of cyclophospha mide 
(from Sigma Chemical Co., St. Louis, Missouri ), pentobarbital sodium 
injection, USP (from Abbott Laboratories, North Chicago, Illinois). 1-
fluoro-2,4 -dinitrobenzene (from Eastman Kodak Co. , Rocheste r, New 
York) and RPM I 1640 medium (from Gibco Laboratories, Chagrin 
Fa lls, Ohio ). 
A prepa ration of heat-killed Co rynebacterium parvum, originating 
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from cultures deri ved from stra in #11827 of' t he America n T ype Culture 
Coll ec tion , was a gift from Dr. Irving Millman (Fox Chase Cancer 
Ce nter, Phi ladelphia, Pennsylvania). 
Ultraviolet Source 
The UVB sou rce was a bank of 4 FS -20 sunlamp flu orescent tubes. 
These bulbs emit a cont. inuow; spectrum ex tending from about 280-
380 nm , with a peak at about 313 nm. A bank of 4 flu orescent black li ght 
tubes (F -20 13 L) se rved as the source of UV A energy. The spectrum 
extends from 000 nm to about 400 nm, peaking a t 360 nm. Both sources 
have a minor outpu t of vis ible light. lrradiance was measured with 
calib rated, cosine-corrected, phot.odiode-type detecto rs using an Inter-
national Light model IL700 resea rch radiometer. For UVB, a model 
SEE-240 detector , equipped with an interfe rence (iJter with spectra l 
respon se from 270- 320 nm (peak response a t 297 nm), was used. The 
UVA detec tor was a model SEE-010 photodiode wit h a spectral re-
sponse from 300- 400 nm (peak response at 36.5 nm). UVB irradiance 
at skin level was 0.36 m W /cm2 and UVA irradiance was 1.44 m W /cm2 . 
l mmu nnad.iu uant.s 
In some experiment s, on day 1 of photosensitization the mice re-
ceived an in t raderm al injection of C. paruum immediately afte r pho-
toa lle rge n and UV irradiat ion. In such cases, C. paruum was suspended 
in ste rile norma l sa line and each a nimal was given 31 11g (0. 1 ml vol) 
intradermally into each photose nsitizatio n s ite . In other ex periments, 
ce rta in groups of mice rece ived cyclop hosphamide (Cy) (50 or 150 mg/ 
kg) i.p. 2 days prio r to photosensitizat ion. Cy was dissolved in steri le 
normal saline shortly before injection. 
Photosensitization 
Mice were photose nsit ized to sulfa in the followin g manner. On day 
0, sulfa was prepared for injection by dissolving sulfa powder in warmed 
(approx imately 50. C) ste ril e norma l sa line at a concentration of 15 
mg/ml. Both rear fl anks o f' t he mice were clipped a nd 400 mg/ kg of 
sulfa was adm iniste red i.p . to each animal. T he mice were kept in the 
da rk for 1 h a nd then anest hetized wit h pentobarbital solu tion (6.66 
mg/ml ; distilled H 20:70% ethanol, 5: I ) at a dose of 0.08 ml/10 g body 
weight. Afte r being loosely taped to a wooden board in the prone 
position, eac h mouse was given UVB (0. 1 J /cm2 ) followed by UV A (5 
.Jfc m2 ) direc ted at t he clipped fl ank a rea. The ears were shielded with 
seve ral laye rs of paper towelin g. The sa me photosensitiza tion procedure 
was repeated on day I with the exception tha t the mice were not 
reclipped. In so me experiments, Cy p ret reatment was adm inistered on 
day - 2 a t a close of 50 o r 150 mg/kg i.p. Control mice rece ived ident ical 
at~ounts of i.p. sulfa on days 0 and 1, but no UV radiation. 
Mice were photose nsit ized to C PZ usin g a similar method but with 
the follow in g noted differences. CPZ was dissolved in steri le normal 
saline at a co ncent ration or 0.2 mg/ml and given at a dose of 5 mg/kg. 
The pentobarbi ta l dose for C PZ-trea ted mice was reduced to 0.06 mlf 
10 g body weight. In a ll C PZ-photosensitized mice, UV ex posure on 
day 1 was foll owed by intraderm al inject ions or the immunoacljuvant 
C. paruum in t.o the se nsiti za tion s it e. 
Phntochallenge 
Putat ive ly photose nsitized a nd co ntro l mice were photochallenged 
on day 5 in t he foll ow in g manner. The mice were anestheti zed and t he 
base line ear th ickn ess was measured with a pocket thickness gauge 
(Peacoc k, .Japan). They then rece ived a n i.p. close of sulfa or CPZ 
identica l to the sensit izing dose give n on days 0 a nd 1. Afte r 1 h in the 
cla rk, t he mice were anesthetized with pentobarb it a l, a nd fixed to a 
wooden board in the la tera l decub itus position. The upside ea r (left) 
was exposed to UVA (5 J /c m2 ) ; t he downside ea r (right) was addition-
a lly shielded with a paper towe l tab to ensure that it rece ived no UVA . 
Vol. 85, No. 3 
Ear swelling was assessed by measurement of ear th ickness at 4, 24, 
and 48 h a fte r photochallenge with the mice under ether a nesthesia. 
Histology 
Ear specimens were obtai ned from experimental and control mice at 
24 and 48 h after photochallenge. The t issue was embedded in paraffin, 
and sections t hat. had been cut at 7 1'111 were stained with hematoxylin-
eosin in the routine way. 
Adoptive Transfer of Photoallergy to Systemic S ulfanilamide 
Donor mice were photosensitized to system ic sulfa by pretreatment 
with Cy, 50 mg/kg, followed 2 days later by i.p. sulfa and UVB-UVA 
as described under "Photosensitization." On day 5, t he mice were 
sacriliced by carbon dioxide asphyxiation and the inguinal lymph nodes 
that drained the photosensitization site were removed and placed in 
RPMI1640 medium on ice. The lymph nodes were minced with scissors 
and forced th rough a wi re-mesh sc reen. After several washings, the 
ce lls were cou nted and percent viab ility was determined by trypan blue 
exc lusion (85- 98% viable). Then t he ce lls were resuspended in saline, 
t heir concentration adjusted to 12.5 X 107/ml a nd 0.4 ml (5 X 107 ce lls) 
was injected i.v. into each rec ipient's ta il ve in . Immediate ly the rec ipi-
ents were photochallenged with i.p. sulfa 400 mg/kg followed in 1 h by 
UVA, 5 J/cm2, to t he left ear. 
Contro l mice received 5 X 107 lymph node cells harvested from 
donors sensitized to topical 0. 5% 1-f1uoro-2,4-dinitrobenzene (DNFB), 
and were photochallengecl in parallel with the experimental group with 
i.p. S'l ifa and UYA. 
Stat istics 
Differences betwee n groups were analyzed by a nonparametric rank 
order, one-way Mann- Whitney test; a p value equal to or less than 0.02 
was considered signi licant 14 1]. 
RESULTS 
Experimental Photoallergy to Systemic Sulfanilamide 
The results of a typica l experime nt are s h own in Table I. 
Female BALB/c X A mice, pretreated with Cy (150 mg/ kg) , 
were photosensitized by i.p. s u lfa followed by UVB a nd UV A 
irradiation to the clipped rear fl a nk . Phototoxicity control 
group animals received drug wit hout UV radiation on days 0 
a nd 1. On day 5, experime ntal mice (group I) and phototoxicity 
controls (group III) were photochallenged with i.p. sulfa fol-
lowed by UV A to t h e le ft ear . A seco nd group of experimental 
mice (group II) was photochallenged with i.p. CPZ and UVA in 
order to test for the spec ificity of the photochallenge reaction. 
There was a s ignifican t increase of left ear thickness at 24 h 
and 48 h in mice photosensitized a nd photochallenged with i.p. 
su lfa. There was n o ear swe lling evident at 4 h after photo-
challen ge, imply ing t hat t h e response was not t h at of a n im -
mediate type hype rsens itivity. S imple a llergic derm atitis to 
s ulfa was not induced in t hese mice as seen by the lack of 
swe lling in the right ears t hat had been challe n ged with drug 
a lone (no UVA). That t h e swelling response was not a photo-
tox ic reaction is ev ide nced by t h e lack of reactions in t h e control 
mice (group III) who were receiving drug a nd UV radiation for 
t h e first time. The photochallenge reactio n was specific for t h e 
drug used at sensitization, a nd could not b e e licited by a CPZ 
photochallenge (see group II). Biopsies from t he left ears were 
obtained in a ll g roups 24 a nd 48 h after photochallenge. At 
'TABLE I. Photosensitization with systemic su.lfan ilamide 
4 h 24 h 48 h 
C roup Day -2 Days 0 and l Day 5 
L R L R L R 
I (6)" Cy ,,0 i.p. sulfa, UVB- i.p. sulfa , UYA L ear 0.2b 0 6.0 -0.5 2.0 -0.7 
UVA to fla nk 
II (6) Cy 1, 0 i.p. sulfa, UVB - i.p. CPZ UVA L ear 0.2 0.7 -0.7 - 0.7 -0.7 -1.0 
UVA to fl ank 
lll (6) Cy 1M1 i.p. sulfa , no UV i.p. sulfa, UVA L ea r -0.2 -0.3 -0.8 -1.0 -0.2 - 0.7 
Left ea r at 24 and 48 h: I > II, p < .005; I > Ill , p < .005. Group 1: L ear > Rea r, p < .005. 
"Number of mi ce in group (13ALB/c X A fema les, 11 weeks old) . 
1
' Mea n increase in ea r thickness (I X 10-2 mm) . 
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both t imes, but only in experimenta l group l mice, t here was 
an inflammatory ce ll perivascula r dermal infiltrate, with some 
stromal edema. This histopathologic picture was typica l of t he 
changes seen wi t h photoallergic contact dermatitis and classical 
alle rgic contact dermatitis in mice [1,2,17, 19,42]. The histology 
of a 24-h positive photochallenge reaction is shown in Fig L 
Exper imental Photoallergy to systemic Chlorpromazine 
In a typ ical expe rimen t, BALB/c X A female mice were 
photosensit ized to systemic CPZ on days 0 and 1 by the i.p. 
injection of CPZ followed by UVB-UVA to clipped f1ank skin. 
Intradermal injection of C. parvum into each sensit ization site, 
F IG L The pos itive challenge reaction to systemic sulfa a nd UVA 
at 24 h shows stromal edema and a peri vascu lar de rmal infiltrate 
consisting main ly of lymphocytes and hist iocyt·es. 
was given immediately after t he UV radiation on day L On day 
5, putatively photosensitized mice, and a control group, were 
photochallenged with i.p. CPZ followed by UV A, 5 J /cm2, to 
t he left ear. As shown in Table II, t he photosensitized animals 
had significant swelling of t he photochallenged ear at 24 h and 
at 48 h , in cont rast to t he control mice of group II who did not 
show a ny ear swelling to an identical photochallenge. 
UVB Radiation is Necessary for Induction of P hotoaLlergic 
Dermatitis to Systemic Sulfanilamide a.nd Systemic 
Chlorpromazine 
Table III out lines an experiment done to asce rta in whether 
UVB, in addit ion to UV A, was necessary to induce photoallergy 
to systemic sulfa. T he data show t hat group I mice, which were 
photosensitized with both UVB and UV A, had positive photo-
challenge reactions, whereas, mice of group II , which received 
only UV A at induction, fai led to become photosensitized. 
A simila r experiment was done fo r systemic CPZ and is 
shown in Table IV. Failure to include UVB at induction re-
sul ted in t he absence of photosensitization. 
Adoptive Transfer of Photoallergic Dermatitis to Systemic 
Sulfanilamide 
Sixty BALB/c X A mice (Table V, group I) were photosen-
sitized to systemic su lfa to serve as donors of lymph node cells 
for t ransfer. On day 5, t hese donor mice were sacrificed, t heir 
ingu inal nodes removed, and a single-cell suspension of lymph 
node cells was prepared. Recipient mice (group II) received 5 
X 107 of t hese lymph node cells i.v. and were then photochal-
lenged with systemic (i.p.) sulfa followed by UVA. Significant 
ear swelling was present in t he left ear at 24 and 48 h . 
Control animals (group IV) received lymph node cells har-
vested in an ident ica l manner from donors (group III) sensit ized 
to topical 0.5% DNFB. Photochallenge of the control group 
was made in pa ra llel; t heir ear photochallenge reactions were 
TABLE II. Photosensitization with systemic chlorpromazine 
----
4 h 24 h 48 h 
G roup Days 0 and l Day 5 
L R L R L R 
I (7)" i.p . CPZ, then UVB-UVA to fl ank; i.p. CPZ, t hen UV A to L ear 0.6 4.3 0.6 2.7 -1.2 
C. paruum on day 1 
-0.9 -1.5 -1.2 -1.6 II (6) i.p. CPZ, no UV i.p. CPZ, t hen UVA to L ear 0 0.3 ----~~----- --------------------~----~----------------------------------------------
Left ear at 24 and 48 h: I > II , p < .005. Group I at 24 and 48 h: L ea r > R ea r, p < .002. 
• umber of mice in group 03ALB/c X A females, 10 weeks old). 
b Mean increase in ea r t hickness ( I x 10-2 mm ). 
TABLE Ill. UVA without UVB fail.~ to induce photoallerr;y to systemic sulfanilamide 
Days 0 
and\ 
24 h 
Group Day -2 Day 5 
L 
I (6)" UVB-UVA Cy ,oo i.p . su lfa, UVB-UVA to f1a nk i.p. sul fa, UVA Lear 6.o• 
II (6) UVA only Cy ,,., i.p . sulfa, UVA to fl ank i.p. sulfa , UVA L ear 0.3 
lll (6) toxicity con tr~ i.p. sulfa, no UV i.p. sulfa, UVA Lear 0 
Left ear at 24 and 48 h: l > II , p < .002, 1 > Ill , p < .002. Group I at 24 and 48 h: Lear> R ear, p < .002. 
• Number of mice in group (BALB/c X A females, 17 weeks old). 
b Mean inc rease in ear thick ness (I X 10- 2 mm ). 
1'ABL8 IV . U\IA withou.L UVB fails to indu.ce photoallergy to systemic ch lorpromazine 
24 h 
Group Day -2 Days 0 and I Day 5 
L 
I (6)" UVB and UVA Cy,.o i. p. CPZ, UVB-UVA, C. paruwn i.p. CPZ, UVA Lear 3.3• 
at day 1 
II (6) UVA only Cy,r,o i.p. CPZ, UVA, C. paruum at i.p. CPZ, UVA Lear 0.2 
day 1 
III (6) toxicity co ntrol i.p. CPZ, no UV i.p. CPZ, UVA Lear 0.5 
Left ear at 24, 48, and 72 h: I > 11, p < .01; I > IJI , p < .005. Group I at 24, 48, and 72 h: L > R, p < .002. 
a Number of mice in group (BALB/c X A females, 17 weeks). 
b Average increase in ear t hickness (1 X lQ- 2 mm). 
R 
-0.7 
-0.3 
-0.3 
R L 
1.2 3.8 
-1.2 0.8 
-0.5 1.0 
48 h 
L R 
9.8 -0.5 
1.0 -0.2 
0.8 0.5 
48 h 
R 
1.3 
-0.8 
-0.2 
72 h 
L R 
7.2 0.3 
1.7 0.7 
0.7 0 
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TABLE V. Adopl£ue transfer of photoallergy to syslem£c su.lfan £lam £de w£lh lymph node cells from actively photosensitized donors 
24 h 48 h 
Group Day -2 Days 0 and 1 Day 5 
L R L R 
I (6)" donors of sulfa 
ce lls 
Cy,," i.p. sulfa, then UVB -U VA to fl anks Inguinal nodes harvested 
II (6) recipient s of' sulfa 
ce lls 
Ill (36) donors of' cont ro l 
ce ll s 
IV (4) recipients of con-
trol ce lls 
V (6) photosensiti zat ion 
positive co ntrol 
5 X 107 lymph node cells IV from group I, 5.0b 0.7 5.5 0.5 
then i.p sulfa and UV A L ear 
Topical DNFB to fl anks Inguinal nodes harvested 
i.p. sulfa, then UVB-UVA to fl anks 
5 X 107 lymph node cel ls IV from group 
Ill , then i.p. sulfa and UVA L ea r 
i. p. sulfa, then UVA L ear 
0.3 0. 3 1.5 0.8 
9.2 2.0 6.0 0.7 
VI (6) tox icity co ntrol i.p. sulfa, no UV i.p. sulfa, then UVA Lear 0.8 1.2 2.2 0.8 
----
Lef't ea r at24 and 48 h: II > IV, p < .01 5; V > VI , p < .002. Group II at 24 and 48 h: L > R, p < .002. Group V: L > R, p < .005. 
"Number of mice in group (BALB/c X A females, 9 weeks old). 
1
' Ave rage in crease in ea r t hickness (1 x 10- 2 rnm). 
negative at a ll measurements. The positive photochallenge 
reactions in group V mi ce demonstrated t hat the donor mice of 
group I had indeed been photose nsitized to systemic sulfa. 
DISCUSSION 
In the experiments described here, systemic photoallergy to 
sulfa and to CPZ was induced in mice by the i.p. administration 
of drug foll owed by UV irradiation of the skin. We demonstra-
ted that the reactions at photoc ha llenge were not phototoxic 
s ince prev ious exposure, i.e., prior photose nsitization, was nec-
essary to e li cit t he response. The specific, acquired , altered 
reactivity was adoptively t rans ferred to naive mice with lymph 
node ce ll s ta ke n from photosensitized donors. The histologic 
picture see n in the pos itive photocha llenge sites consisted of 
a n int radermal lympho histiocytic infiltrate which is simi lar to 
the pathology seen in photoall ergic contact dermatitis and 
a llergic contact dermatiti s in mice . 
UV A with out U VB radiation fails to induce photoallergy to 
system ic sulfa and CPZ. The mechanism of the effect is not 
known , bu t UVB serves a fun ction that ca nnot be substituted 
for by Cy or C. parvum immunopotentiators. It is interesting 
t hat in the case of photoallergic co ntact derm atitis to 3,3 ' ,4' ,5-
tetrac hl orosa licylani lide (TCSA), UVB is not required for pho-
tose nsiti zat ion [1 7,18,43]. 
Curre ntly, the re a re two main theories rega rding the role of 
UV radiat ion in the generation o f photoa llergen. One purports 
t hat t he photosensitizer is a prohapten which is converted by 
photons to a stable hapten [7 ,38,44 ]. The other t heory proposes 
t hat the photose ns itize r is a ha pten that is act ivated by UV 
radiati on to a t rans ient free radica l which the n binds to a 
nearby protein to form a complete antigen [38,45,46]. Support 
for the stable hapte n co ncept is found in the experiments 
reported in 1957 by Schwarz and Speck [11] with the in vitro 
photoproduct of sulfa, para-hydroxy lamino benzene su lfona-
mide (PHABSA). These in vestiga tors photose nsitized guinea 
pigs to sulfa a nd UV and were able to successfully chall enge 
those guinea p igs with PHABS a lone. Further, guinea pigs 
sensitized to PHABSA had pos it ive photocha llenge reactions 
to sulfa foll owed by UV radi ation. 
More rece ntly, in our laborato ry, we have found t hat mice 
contact- photose ns iti zed to CPZ or to sulfa could be success fully 
cha ll enged with in vitro irradiated homologous drug [47]. Al so, 
mice which we photosensitized by the intradermal injection of 
in vitro irradiated CPZ or s ulia gave posit ive photocha lle nge 
reactions to percuta neous drug followed by UVA [48 ]. These 
findin gs suggested that, at least in th e instance of CPZ and 
sulfa, in vitro UV irradiation caused the formation of a stab le 
photop roduct. (hapten) whi ch acted as a n ordinary contact 
a ll erge n. Curre ntly we are investigating th is issue in the case 
o f the murine model of photodermatiti s to systemic chemica ls. 
In the prese nt ex periments mice were photose ns itized by t he 
parentera l (i.p.) adm ini stration of photose nsiti zer. In the case 
of a llergic contact dermatitis, generally it has been observed 
that parenteral or oral adm inistration of antigen leads to spe-
cific immunologic tolerance, rather than sensitization; one ex-
planation given for th is finding is that t he antigen contacts 
lymphoid cells directly thereby bypassing a population of effec-
tive antigen-p resenting cells [39,40) . In our experiments with 
the i.p. adm inistration of sensitizer, we consistently achieved 
sens itization, not to lerance. A likely expla nation for this is that 
the proximal a llergen is formed in t he skin where there is an 
abundance of antige n-presenting ce lls , especia lly Langerhans 
cells. 
In summary, we have established an experimental model for 
photoallergy to systemic drugs, an entity which previously had 
been suspected to ex ist on the basis of clinical case reports. We 
have demonstrated t hat it does not represent phototoxicity and 
t hat cutaneous exposure is not required for photosensitization 
to take place. This murine model will facilitate the elucidation 
of the mechanisms of photoa llergy to systemic drugs and, 
perhaps, will be the basi s for the screening of systemic drugs 
for their possible photoallergenicity in humans. 
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